Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose oral tapentadol pharmacokinetics in young children with acute pain
2019-000205-77Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tapentadol in acute pain, sponsored by Grünenthal GmbH. Primary endpoint: Area under the concentration-time curve at steady state for the dosing interval (AUCtau,SS) for tapentadol. Started Jun 2019; status: completed.
02
Drugs
tapentadol
03
Conditions
acute pain
Beyond the preview
Go deeper on 2019-000205-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000205-77.